HR+/HER2- BREAST CANCER: THE GROWING ROLE OF ADVANCED DRUG TREATMENTS

Advancements in HR+/HER2- Breast Cancer Treatment HR+/HER2- breast cancer is among the most common subtypes, affecting a substantial patient population globally. As oncology research advances, new drug candidates are emerging, poised to revolutionize HR+/HER2- breast cancer treatment. These innovative therapies aim to enhance efficacy, improve pat